Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis.
Aizu M, Mizushima I, Nakazaki S, Nakashima A, Kato T, Murayama T, Kato S, Katsuki Y, Ogane K, Fujii H, Yamada K, Nomura H, Yachie A, Yamagishi M, Kawano M.
Aizu M, et al. Among authors: nakashima a.
Mod Rheumatol. 2018 Jul;28(4):592-598. doi: 10.1080/14397595.2017.1370766. Epub 2017 Sep 12.
Mod Rheumatol. 2018.
PMID: 28880691